ArticleCell journal2024

Atorvastatin's Therapeutic Potential in Atherosclerosis: Inhibiting TGF-β-Induced Proteoglycan Glycosaminoglycan Chain Elongation through ROS-ERK1/2-Smad2L Signaling Pathway Modulation in Vascular Smooth Muscle Cells.

Hossein Ghaderi-Zefrehi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.